<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="28/06/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7983701" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>7983701</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term sem="Virus" id="T1" lex="human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</term> replication by a <term sem="DNA_domain_or_region" id="T2" lex="Tat-activated,_transduced_interferon_gene"><term sem="Protein_molecule" id="A1">Tat</term>-activated, transduced <term sem="DNA_domain_or_region" id="A2">interferon gene</term></term>: targeted expression to <term sem="Cell_natural" id="T3" lex="human_immunodeficiency_virus_type_1-infected_cell"><term sem="Virus" id="T4" lex="human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</term>-infected cells</term>.</sentence>
<event id="E1">
<type class="Viral_life_cycle" />
<theme idref="T1" />
<clue>Inhibition of human immunodeficiency virus type 1 <clueType>replication</clueType> by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="A1" />
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-<clueType>activated</clueType>, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="E2" />
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus type 1 replication <linkCause>by</linkCause> a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event id="E4">
<type class="Gene_expression" />
<theme idref="A2" />
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted <clueType>expression</clueType> to <clueLoc>human immunodeficiency virus type 1-infected cells.</clueLoc></clue>
</event>
<event id="E51">
<type class="Viral_life_cycle" />
<theme idref="T4" />
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-<clueType>infected</clueType> cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We have examined the feasibility of using <term sem="Other" id="T5" lex="interferon_(IFN)_gene_transfer"><term sem="Protein_family_or_group" id="T6" lex="interferon">interferon</term> (<term sem="Protein_family_or_group" id="T7" lex="IFN">IFN</term>) gene transfer</term> as a novel approach to <term sem="Other" id="T8" lex="anti-human_immunodeficiency_virus_type_1_(HIV-1)_therapy">anti-<term sem="Virus" id="T9" lex="human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</term> (HIV-1) therapy</term> in this study.</sentence>
<sentence id="S3">To limit expression of a transduced <term sem="DNA_domain_or_region" id="T10" lex="HIV-1_long_terminal_repeat_(LTR)-IFNA2">HIV-1 long terminal repeat (LTR)-IFNA2</term> (the new approved nomenclature for <term sem="DNA_family_or_group" id="T11" lex="IFN_gene">IFN genes</term> is used throughout this article) <term sem="DNA_family_or_group" id="T12" lex="hybrid_gene">hybrid gene</term> to the <term sem="Cell_cultured" id="T13" lex="HIV-1-infected_cell">HIV-1-infected cells</term>, <term sem="DNA_domain_or_region" id="T14" lex="HIV-1_LTR">HIV-1 LTR</term> was modified.</sentence>
<event id="E5">
<type class="Gene_expression" />
<theme idref="T10" />
<clue>To limit <clueType>expression</clueType> <linkTheme>of</linkTheme> a transduced HIV-1 long terminal repeat (LTR)-IFNA2 (the new approved nomenclature for IFN genes is used throughout this article) hybrid gene to the <clueLoc>HIV-1-infected cells</clueLoc>, HIV-1 LTR was modified.</clue>
</event>
<event id="E52">
<type class="Viral_life_cycle" />
<theme idref="T10" />
<clue>To limit expression of a transduced HIV-1 long terminal repeat (LTR)-IFNA2 (the new approved nomenclature for IFN genes is used throughout this article) hybrid gene to the HIV-1-<clueType>infected</clueType> cells, HIV-1 LTR was modified.</clue>
</event>
<sentence id="S4">Deletion of the <term sem="DNA_family_or_group" id="T15" lex="NF-kappa_B_element"><term sem="Protein_molecule" id="T16" lex="NF-kappa_B">NF-kappa B</term> elements</term> of the <term sem="DNA_domain_or_region" id="T17" lex="HIV-1_LTR">HIV-1 LTR</term> significantly inhibited <term sem="Other" id="T18" lex="Tat-mediated_transactivation"><term sem="Protein_molecule" id="T19" lex="Tat">Tat</term>-mediated transactivation</term> in <term sem="Cell_cultured" id="T20" lex="T-cell_line">T-cell lines</term>, as well as in a <term sem="Cell_cultured" id="T21" lex="monocyte_line">monocyte line</term>, <term sem="Cell_cultured" id="T22" lex="U937">U937</term>.</sentence>
<event id="E6">
<type class="Mutagenesis" />
<theme idref="T15" />
<clue><clueType>Deletion</clueType> <linkTheme>of</linkTheme> the NF-kappa B elements <clueLoc>of the HIV-1 LTR</clueLoc> significantly inhibited Tat-mediated transactivation in T-cell lines, as well as in a monocyte line, U937.</clue>
<comment>Artificial</comment>
</event>
<event id="E7">
<type class="Positive_regulation" />
<cause idref="T19" />
<clue>Deletion of the NF-kappa B elements of the HIV-1 LTR significantly inhibited Tat-<linkCause>mediated</linkCause> <clueType>transactivation</clueType> in T-cell lines, as well as in a monocyte line, U937.</clue>
</event>
<event id="E8">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="E6" />
<clue>Deletion of the NF-kappa B elements of the HIV-1 LTR significantly <clueType>inhibited</clueType> Tat-mediated transactivation <clueLoc>in T-cell lines, as well as in a monocyte line, U937.</clueLoc></clue>
</event>
<sentence id="S5">Replacement of the <term sem="DNA_domain_or_region" id="T23" lex="NF-kappa_B_element"><term sem="Protein_molecule" id="T24" lex="NF-kappa_B">NF-kappa B</term> elements</term> in the <term sem="DNA_domain_or_region" id="T25" lex="HIV-1_LTR">HIV-1 LTR</term> by a <term sem="DNA_molecule" id="T26" lex="DNA_fragment">DNA fragment</term> derived from the <term sem="DNA_domain_or_region" id="T27" lex="5&apos;-flanking_region">5&apos;-flanking region</term> of <term sem="DNA_domain_or_region" id="T28" lex="IFN-stimulated_gene_15">IFN-stimulated gene 15</term> (<term sem="DNA_domain_or_region" id="T29" lex="ISG15">ISG15</term>), containing the <term sem="DNA_domain_or_region" id="T30" lex="IFN-stimulated_response_element">IFN-stimulated response element</term>, partially restored <term sem="Other" id="T31" lex="Tat-mediated_activation"><term sem="Protein_molecule" id="T32" lex="Tat">Tat</term>-mediated activation</term> of <term sem="DNA_domain_or_region" id="T33" lex="LTR">LTR</term> in <term sem="Cell_natural" id="T34" lex="T_cell">T cells</term> as well as in <term sem="Cell_natural" id="T35" lex="monocyte">monocytes</term>.</sentence>
<event id="E9">
<type class="Mutagenesis" />
<theme idref="T23" />
<theme idref="T29" />
<clue><clueType>Replacement</clueType> <linkTheme>of</linkTheme> the NF-kappa B elements <clueLoc>in the HIV-1 LTR</clueLoc> <linkTheme>by</linkTheme> a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially restored Tat-mediated activation of LTR in T cells as well as in monocytes.</clue>
<comment>Artificial</comment>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="T32" />
<clue>Replacement of the NF-kappa B elements in the HIV-1 LTR by a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially restored Tat-<linkCause>mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> LTR in T cells as well as in monocytes.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E9" />
<clue>Replacement of the NF-kappa B elements in the HIV-1 LTR by a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially <clueType>restored</clueType> Tat-mediated activation of LTR <clueLoc>in T cells as well as in monocytes</clueLoc>.</clue>
</event>
<sentence id="S6">Insertion of this <term sem="DNA_family_or_group" id="T36" lex="chimeric_promoter">chimeric promoter</term> (<term sem="DNA_domain_or_region" id="T37" lex="ISG15_LTR">ISG15 LTR</term>) upstream of the <term sem="DNA_domain_or_region" id="T38" lex="human_IFNA2_gene">human IFNA2 gene</term> directed high levels of <term sem="Other" id="T39" lex="IFN_synthesis"><term sem="Protein_family_or_group" id="T40" lex="IFN">IFN</term> synthesis</term> in <term sem="Cell_cultured" id="T41" lex="Tat-expressing_cell"><term sem="Protein_molecule" id="A24">Tat</term>-expressing cells</term>, while this promoter was not responsive to <term sem="Other" id="T42" lex="tumor_necrosis_factor_alpha-mediated_activation"><term sem="Protein_molecule" id="T43" lex="tumor_necrosis_factor_alpha">tumor necrosis factor alpha</term>-mediated activation</term>.</sentence>
<event id="E12">
<type class="Gene_expression" />
<theme idref="T40" />
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN <clueType>synthesis</clueType> in Tat-expressing cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<event id="E13">
<type class="Mutagenesis" />
<theme idref="T37" />
<clue><clueType>Insertion</clueType> <linkTheme>of</linkTheme> this chimeric promoter (ISG15 LTR) <clueLoc>upstream of the human IFNA2 gene</clueLoc> directed high levels of IFN synthesis in Tat-expressing cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
<comment>Artificial</comment>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="E13" />
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene <clueType>directed</clueType> high levels of IFN synthesis <clueLoc>in Tat-expressing cells</clueLoc>, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<event assertion="non-exist" id="E15">
<type class="Positive_regulation" />
<theme idref="T37" />
<cause idref="T43" />
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat-expressing cells, while <corefTheme>this promoter</corefTheme> was not responsive to tumor necrosis factor alpha-<linkCause>mediated</linkCause> <clueType>activation</clueType>.</clue>
</event>
<event id="E66">
<type class="Gene_expression" />
<theme idref="A24" />
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat-<clueType>expressing</clueType> cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<sentence id="S7"><term sem="DNA_domain_or_region" id="T44" lex="ISG15-LTR-IFN_hybrid_gene">ISG15-LTR-IFN hybrid gene</term> inserted into the <term sem="DNA_molecule" id="T45" lex="retrovirus_vector">retrovirus vector</term> was transduced into <term sem="Cell_cultured" id="T46" lex="Jurkat">Jurkat</term> and <term sem="Cell_cultured" id="T47" lex="U937_cell">U937 cells</term>.</sentence>
<event id="E16">
<type class="Artificial_process" />
<theme idref="T44" />
<theme idref="T46" />
<clue>ISG15-LTR-IFN hybrid gene inserted into the retrovirus vector was <clueType>transduced</clueType> <linkTheme>into</linkTheme> Jurkat and U937 cells.</clue>
</event>
<event id="E17">
<type class="Artificial_process" />
<theme idref="T44" />
<theme idref="T47" />
<clue>ISG15-LTR-IFN hybrid gene inserted into the retrovirus vector was <clueType>transduced</clueType> <linkTheme>into</linkTheme> Jurkat and U937 cells.</clue>
</event>
<sentence id="S8">Selected <term sem="Cell_cultured" id="T48" lex="transfected_clone">transfected clones</term> produced low levels of <term sem="Protein_molecule" id="T49" lex="IFN_A">IFN A</term> (<term sem="Protein_molecule" id="T50" lex="IFNA">IFNA</term>) constitutively, and their abilities to express <term sem="Protein_molecule" id="T51" lex="interleukin-2">interleukin-2</term> and <term sem="Protein_molecule" id="T52" lex="interleukin-2_receptor"><term sem="Protein_molecule" id="T53" lex="interleukin-2">interleukin-2</term> receptor</term> upon stimulation with <term sem="Protein_molecule" id="T54" lex="phytohemagglutinin">phytohemagglutinin</term> and <term sem="Organic_compound_other" id="T55" lex="phorbol_myristate_acetate">phorbol myristate acetate</term> were retained.</sentence>
<event id="E18">
<type class="Gene_expression" />
<theme idref="T50" />
<clue>Selected transfected clones <clueType>produced</clueType> low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E19">
<type class="Gene_expression" />
<theme idref="T51" />
<clue>Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to <clueType>express</clueType> interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E20">
<type class="Gene_expression" />
<theme idref="T52" />
<clue>Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to <clueType>express</clueType> interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E19" />
<cause idref="T54" />
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="E20" />
<cause idref="T54" />
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="E19" />
<cause idref="T55" />
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="E20" />
<cause idref="T55" />
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<sentence id="S9">Enhancement of <term sem="Other" id="T56" lex="IFNA_synthesis"><term sem="Protein_molecule" id="T57" lex="IFNA">IFNA</term> synthesis</term> observed upon <term sem="Other" id="T58" lex="HIV-1_infection"><term sem="Virus" id="T59" lex="HIV-1">HIV-1</term> infection</term> resulted in significant inhibition of <term sem="Other" id="T60" lex="HIV-1_replication"><term sem="Virus" id="T61" lex="HIV-1">HIV-1</term> replication</term> for a period of at least 30 days.</sentence>
<event id="E25">
<type class="Gene_expression" />
<theme idref="T57" />
<clue>Enhancement of IFNA <clueType>synthesis</clueType> observed upon HIV-1 infection resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event id="E26">
<type class="Initiation_of_viral_infection" />
<theme idref="T59" />
<clue>Enhancement of IFNA synthesis observed upon HIV-1 <clueType>infection</clueType> resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="E25" />
<cause idref="E26" />
<clue><clueType>Enhancement</clueType> <linkTheme>of</linkTheme> IFNA synthesis observed <linkCause>upon</linkCause> HIV-1 infection resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event id="E28">
<type class="Viral_life_cycle" />
<theme idref="T61" />
<clue>Enhancement of IFNA synthesis observed upon HIV-1 infection resulted in significant inhibition of HIV-1 <clueType>replication</clueType> for a period of at least 30 days.</clue>
</event>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="E27" />
<clue>Enhancement of IFNA synthesis observed upon HIV-1 infection resulted in significant <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV-1 replication <clueTime>for a period of at least 30 days</clueTime>.</clue>
</event>
<sentence id="S10"><term sem="Virus" id="A5">Virus isolated from <term sem="Cell_cultured" id="T62" lex="IFNA-producing_cell"><term sem="Protein_molecule" id="T63" lex="IFNA">IFNA</term>-producing cells</term></term> was able to replicate in the <term sem="Cell_cultured" id="T64" lex="U937_cell">U937 cells</term> but did not replicate efficiently in <term sem="Cell_cultured" id="T65" lex="U937_cell">U937 cells</term> transduced with the <term sem="DNA_domain_or_region" id="T66" lex="IFNA_gene"><term sem="Protein_molecule" id="T67" lex="IFNA">IFNA</term> gene</term>.</sentence>
<event id="E30">
<type class="Viral_life_cycle" />
<theme idref="A5" />
<clue>Virus isolated from IFNA-producing cells was able to <clueType>replicate</clueType> <clueLoc>in the U937 cells</clueLoc> but did not replicate efficiently in U937 cells transduced with the IFNA gene.</clue>
<comment>TPS: A5</comment>
</event>
<event id="E70">
<type class="Gene_expression" />
<theme idref="T63" />
<clue>Virus isolated from IFNA-<clueType>producing</clueType> cells was able to replicate in the U937 cells but did not replicate efficiently in U937 cells transduced with the IFNA gene.</clue>
</event>
<event assertion="non-exist" id="E31">
<type class="Viral_life_cycle" />
<theme idref="A5" />
<clue>Virus isolated from IFNA-producing cells was able to replicate in the U937 cells but did not <clueType>replicate</clueType> efficiently <clueLoc>in U937 cells transduced with the IFNA gene.</clueLoc></clue>
</event>
<event id="E32">
<type class="Artificial_process" />
<theme idref="T65" />
<theme idref="T66" />
<clue>Virus isolated from IFNA-producing cells was able to replicate in the U937 cells but did not replicate efficiently in U937 cells <clueType>transduced</clueType> <linkTheme>with</linkTheme> the IFNA gene.</clue>
</event>
<sentence id="S11">These results suggest that targeting <term sem="Other" id="T68" lex="IFN_synthesis"><term sem="Protein_family_or_group" id="T69" lex="IFN">IFN</term> synthesis</term> to <term sem="Cell_cultured" id="T70" lex="HIV-1-infected_cell"><term sem="Virus" id="T71" lex="HIV-1">HIV-1</term>-infected cells</term> is an attainable goal and that autocrine <term sem="Other" id="T72" lex="IFN_synthesis"><term sem="Protein_family_or_group" id="T73" lex="IFN">IFN</term> synthesis</term> results in a long-lasting and permanent suppression of <term sem="Other" id="T74" lex="HIV-1_replication"><term sem="Virus" id="T75" lex="HIV-1">HIV-1</term> replication</term>.</sentence>
<event id="E33">
<type class="Gene_expression" />
<theme idref="T69" />
<clue>These results suggest that targeting IFN <clueType>synthesis</clueType> to <clueLoc>HIV-1-infected cells</clueLoc> is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
<event id="E34">
<type class="Gene_expression" />
<theme idref="T73" />
<clue>These results suggest that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN <clueType>synthesis</clueType> results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
<event id="E35">
<type class="Viral_life_cycle" />
<theme idref="T75" />
<clue>These results suggest that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 <clueType>replication</clueType>.</clue>
</event>
<event uncertainty="probable" id="E36">
<type class="Negative_regulation" />
<theme idref="E35" />
<cause idref="E34" />
<clue>These results suggest that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent <clueType>suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event uncertainty="probable" id="E71">
<type class="Viral_life_cycle" />
<theme idref="T71" />
<clue>These results suggest that targeting IFN synthesis to HIV-1-<clueType>infected</clueType> cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
